Construction of a screening system for lipid-derived radical inhibitors and validation of hit compounds to target retinal and cerebrovascular diseases.
Mori R, Abe M, Saimoto Y, Shinto S, Jodai S, Tomomatsu M, Tazoe K, Ishida M, Enoki M, Kato N, Yamashita T, Itabashi Y, Nakanishi I, Ohkubo K, Kaidzu S, Tanito M, Matsuoka Y, Morimoto K, Yamada KI.
Mori R, et al. Among authors: enoki m.
Redox Biol. 2024 Jul;73:103186. doi: 10.1016/j.redox.2024.103186. Epub 2024 May 8.
Redox Biol. 2024.
PMID: 38744193
Free PMC article.